Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

A Polyclonal Antibody to NKX3.1 Identifies Fungal Organisms From the Esophagus

Pejchal, Martina, MD, PhD*; Pai, Reetesh K., MD*; Habib-Bein, Nadia F., MBCHB, PhD*,†; Barasch, Nicholas J., MD*; Hartman, Douglas J., MD*

Applied Immunohistochemistry & Molecular Morphology: January 2019 - Volume 27 - Issue 1 - p 81–85
doi: 10.1097/PAI.0000000000000528
Technical Article
Buy
SDC

NKX3.1 is a transcription factor used to identify prostatic adenocarcinomas. We describe novel functionality for NKX3.1 compared with Grocott and periodic acid-Schiff-diastase (PASD) on esophageal biopsies. We identified esophageal biopsies on the basis of the search term “candida” from March 28, 2012 to December 27, 2013. Of 85 cases for which 3 stains were available and at least 1 stain was positive for fungus consistent with Candida, 83 cases stained as positive with NKX3.1, compared with 79 with PASD and 75 with Grocott. NKX3.1 was significantly superior to Grocott but not to PASD (P<0.05). NKX3.1 was significantly more efficacious in leading to a positive diagnosis of esophageal candidiasis compared with Grocott, resulting in a significantly higher number of positive fragments per slide as well as the number of organisms per fragment, but not PASD. NKX3.1 will be useful to add to the stain armamentarium for Candida and possibly other fungal organisms.

*Department of Anatomic Pathology, University of Pittsburgh Medical Center

Department of Anatomic Pathology, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA

Presented as a poster at the 2016 Annual Meeting of United States and Canadian Association of Pathology (USCAP).

The authors declare no conflict of interest.

Reprints: Douglas J. Hartman, MD, Department of Anatomic Pathology, University of Pittsburgh Medical Center, 200 Lothrop St, Rm. A610, Pittsburgh, PA 15213 (e-mail: hartmandj@upmc.edu).

Received January 31, 2017

Accepted March 25, 2017

Copyright 2019 Wolters Kluwer Health, Inc. All rights reserved.